AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
FARXIGA has 15.7 points less BS than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech BS: FARXIGA (farxiga.com)
FARXIGA.com is a high-substance, low-fluff pharmaceutical portal that sacrifices digital authority markers for legal compliance. It is factually dense but technically invisible to structured search, relying entirely on the weight of its clinical data rather than modern trust-building signals.
Implement comprehensive Physician and Drug schema.org structured data to link the brand to its FDA-approved indications. Replace empty H1 and H2 placeholders on indication-specific pages with keyword-rich condition descriptions to fix the technical hierarchy. Add direct outbound links to published clinical trial results on PubMed or ClinicalTrials.gov to provide a legitimate proof path beyond internal PDFs.
The site exhibits high information density with a low ratio of fluff to substance. Body text contains specific clinical metrics such as ‘A1C reduction of up to 2.1%’ and references to technical diagnostic tests like ‘eGFR’ and ‘UACR.’ Headings are largely functional rather than hyperbolic, though the H1 ‘Welcome to FARXIGA’ is structurally weak.
AI treats every internal link as a semantic statement — not a navigation hint. Validate your entity level link signals and confirm whether your anchors reinforce meaning or generate noise.
There is zero semantic drift between the homepage signal and sub-page substance. The homepage H1 and meta-description promise coverage of CKD, Heart Failure, and T2D, and each strategically selected sub-page delivers deep-dive content specifically for those indications without shifting target audiences or value propositions.
Identify the current state and friction diagnosis of your specific business model. Generate your Executive SEO Strategy to quantify the financial or conversion cost of strategic misalignment.
While the site uses the word ‘proven’ 12 times across the crawled pages, it fails the proof path test with a proof_links_count of 0. It relies on internal ‘Prescribing Information’ and ‘Medication Guides’ rather than linking to external peer-reviewed studies or ClinicalTrials.gov identifiers, creating a circular trust loop typical of big pharma portals.
Proof density is high regarding clinical outcomes (e.g., ‘1 in 8 deaths associated with heart failure’) but low regarding external verification. The site provides 8+ instances of specific evidence per page, yet these are presented as internal facts rather than verifiable external proof points.
For a concrete demonstration of how the methodology exposes structural, semantic, and commercial gaps in a real hospitality brand, review a full executive level diagnostic applied to a coastal 4 star resort. View the Connemara Coast Hotel Executive SEO Strategy to see how positioning drift, UX friction, and experience SEO failures are surfaced in practice.
The site matches several industry clichés such as ‘clinical trial data’ and ‘trusted by healthcare professionals,’ but avoids the most egregious value prop cliches. The ‘Pay $0’ offer is a common industry pattern, yet the high degree of specificity regarding medical indications prevents the site from feeling like a generic commodity template.
A significant authority gap exists due to the total absence of JSON-LD schema (schema_json is null) and a lack of named medical experts or contributors. Furthermore, technical credibility is hampered by poor heading hierarchy on sub-pages where H1 and H2 tags are occasionally empty or missing in the structured crawl data.
The marketing tone is restrained and clinically focused. Performance claims like ‘reduce the risk of cardiovascular death’ are backed by specific situational parameters (e.g., ‘in adults with heart failure’) rather than vague breakthrough promises, though the lack of direct data citations remains a minor disconnect.
Medical Devices, Pharma & Biotech BS: FARXIGA (farxiga.com)
The content perfectly aligns with the Pharmaceuticals category, specifically focusing on SGLT2 inhibitors for chronic kidney disease, heart failure, and type 2 diabetes. The presence of extensive Important Safety Information (ISI) and commercial eligibility terms is characteristic of the highly regulated US pharmaceutical industry.
AI retrieval begins with one question: "What is this page?" Read the Structured Data Technical Guide to learn how correct entity typing and persistent identifiers prevent your site from collapsing into noise.
“The score of 25 is primarily generated by Step 3 (Trust and Proof) and Step 5 (Identity and Authority). The lack of external proof paths and total absence of structured schema represent the only significant bullshit patterns on an otherwise substance-heavy medical site.”
Analysis Disclosure & Source Attribution
Snapshot Date: May 30, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at FARXIGA to view the most current version of their content and see directly what the company offers.